RxDoctor Payments Data

Giselle Deiros

Pediatrics · Miami, FLNPI 1316434186

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $513 of the $832 with a category attached, or 61.6%. Merck accounts for 86.8% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $676, more than ten times the $58 reported in 2020.

$832in general payments, 2019–2025

Across 13 payments — averaging $64.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$722
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$27
  • Takeda Pharmaceuticals U.S.A., Inc.$26
  • Biogen$20
  • Seqirus USA Inc$19
  • Adlon Therapeutics L.p.$18
$1,110,979in research payments, 2019–2025

Across 192 payments — averaging $5786.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi Pasteur Inc.$507K
  • Teva Pharmaceuticals USA, Inc.$257K
  • Bavarian Nordic A/s$232K
  • GSK$72K
  • Sekisui Diagnostics LLC$44K

What the payments were for

  • Travel & lodging$31938%
  • Food & beverage$51362%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$832 in reported general payments places this provider in the 80th percentile of 3,964 pediatrics providers in Florida.

See all pediatrics providers in Florida

Other pediatrics in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →